IRIDEX CORP (IRIX)
US4626841013 - Common Stock
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Iridex (NASDAQ:IRIX) just reported results for the fourth quarter of 2023.Iride...
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
Advances strategic review to unlock shareholder value
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
Advances strategic review to unlock shareholder value...
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
MOUNTAIN VIEW, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile...
Iridex Corporation Receives European Patent on MicroPulse Technology
The Advanced Short Pulse Laser System
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare...
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
MOUNTAIN VIEW, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, a global leader in innovative laser-based medical systems for the treatment...
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment...
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
MOUNTAIN VIEW, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile...
Iridex Reports Third Quarter 2023 Financial Results and Business Update
Iridex Reports Third Quarter 2023 Financial Results and Business Update
MOUNTAIN VIEW, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile...
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
The Company also announced plans to present at Stifel Healthcare Conference
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
The Company also announced plans to present at Stifel Healthcare Conference...
Iridex to Report Third Quarter Financial Results on November 14, 2023
Iridex to Report Third Quarter Financial Results on November 14, 2023
MOUNTAIN VIEW, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical...
Iridex announces review of strategic alternatives, stock rises (NASDAQ:IRIX)
Iridex (IRIX) said on Tuesday that it was conducting a review of its strategic alternatives. Shares of IRIX jumped 2.7% in extended trading. The company added that it had hired...
Iridex Announces Strategic Review to Unlock Shareholder Value
Iridex Announces Strategic Review to Unlock Shareholder Value
MOUNTAIN VIEW, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) announced today that its Board of Directors is undertaking, in...
Iridex Reports Second Quarter 2023 Financial Results